These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Retinopathy as a result of long-term use of thioridazine. Borodoker N; Del Priore LV; De A Carvalho C; Yannuzzi LA Arch Ophthalmol; 2002 Jul; 120(7):994-5. PubMed ID: 12096981 [No Abstract] [Full Text] [Related]
13. Clinical-ultrastructural study of thioridazine retinopathy. Miller FS; Bunt-Milam AH; Kalina RE Ophthalmology; 1982 Dec; 89(12):1478-88. PubMed ID: 7162792 [TBL] [Abstract][Full Text] [Related]
14. Pigmentary retinopathy associated with low-dose thioridazine treatment. Lam RW; Remick RA Can Med Assoc J; 1985 Apr; 132(7):737. PubMed ID: 3978494 [No Abstract] [Full Text] [Related]
15. [Mechanism of the development of thioridazine retinopathy]. Ivanina TA; Lebedeva MN; Sakina NL Biull Eksp Biol Med; 1988 Jan; 105(1):22-5. PubMed ID: 3337876 [TBL] [Abstract][Full Text] [Related]
16. Clinical experience with Melleril-Retard. Svestka J; Náhunek K Act Nerv Super (Praha); 1970; 12(3):245-6. PubMed ID: 5457439 [No Abstract] [Full Text] [Related]
17. Progressive severe visual loss after long-term withdrawal from thioridazine treatment. Chaudhry IA; Shamsi FA; Weitzman ML Eur J Ophthalmol; 2006; 16(4):651-3. PubMed ID: 16952115 [TBL] [Abstract][Full Text] [Related]